International Conference on Immunology, Vaccine Development, and Translational Science
(ICIVDTS-26)

13th December 2026 || Pune - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Immunology, Vaccine Development, and Translational Science (ICIVDTS), scheduled to be held on 13th December 2026 in Pune, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of HIV/AIDS.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in HIV Immunology
    This track focuses on the latest discoveries in the immunological responses to HIV infection. Researchers will present findings on immune evasion mechanisms and the role of T cells in controlling viral replication. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Innovative Vaccine Technologies Against HIV
    This session will explore cutting-edge vaccine platforms and technologies aimed at eliciting robust immune responses against HIV. Discussions will include mRNA vaccines, viral vectors, and nanoparticle-based approaches. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 03 – Translational Research in HIV Vaccine Development
    This track emphasizes the translation of basic immunological research into effective HIV vaccine candidates. Presentations will highlight successful case studies and ongoing clinical trials. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Immune Response Dynamics in HIV Infection
    This session will delve into the complexities of the immune response during HIV infection, including the roles of antibodies and cellular immunity. Researchers will discuss the implications of these dynamics for vaccine design. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Adjuvants in HIV Vaccine Formulation
    This track will focus on the role of adjuvants in enhancing the immunogenicity of HIV vaccines. Presentations will cover novel adjuvant systems and their mechanisms of action in promoting immune responses. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Immunotherapy Approaches in HIV Treatment
    This session will explore the potential of immunotherapeutic strategies in the management of HIV/AIDS. Topics will include immune checkpoint inhibitors and therapeutic vaccines aimed at boosting immune control. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 07 – Clinical Trials and Regulatory Challenges in HIV Vaccines
    This track will address the design and execution of clinical trials for HIV vaccine candidates, highlighting regulatory hurdles and ethical considerations. Experts will share insights on best practices and lessons learned. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 16 – Peace, Justice and Strong Institutions
  • Track 08 – Immune Memory and Long-Term Protection Against HIV
    This session will investigate the mechanisms underlying immune memory in the context of HIV infection and vaccination. Researchers will discuss strategies to enhance durable immune responses. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Pathogen Recognition and Immune Activation in HIV
    This track will focus on the mechanisms of pathogen recognition and subsequent immune activation in HIV. Presentations will highlight the role of pattern recognition receptors and their implications for vaccine development. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Immunogenetics of HIV Susceptibility and Resistance
    This session will explore the genetic factors influencing susceptibility and resistance to HIV infection. Discussions will include the role of host genetics in shaping immune responses and vaccine efficacy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 11 – Future Directions in HIV Vaccine Research
    This track will provide a platform for discussing emerging trends and future directions in HIV vaccine research. Experts will share their visions for innovative strategies to combat HIV/AIDS globally. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 17 – Partnerships for the Goals
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 16 SDG 16
    Peace, Justice and Strong Institutions
  • SDG 17 SDG 17
    Partnerships for the Goals

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228